BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
23 results:

  • 1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic profile and clinical features of MSI-H and TMB-high pancreatic cancers: real-world data from C-CAT database.
    Sakakida T; Ishikawa T; Doi T; Morita R; Kataoka S; Miyake H; Yamaguchi K; Moriguchi M; Sogame Y; Yasuda H; Iwasaku M; Konishi H; Takayama K; Itoh Y
    J Gastroenterol; 2024 Feb; 59(2):145-156. PubMed ID: 38006445
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Case of a Pathological Complete Response to Neoadjuvant Nivolumab plus Ipilimumab in Periampullary Adenocarcinoma.
    Pothuri V; Herndon J; Ballentine SJ; Lim KH; Fields RC
    Oncologist; 2021 Sep; 26(9):722-726. PubMed ID: 33982365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group.
    Breton C; Meyer A; Malka D; Matias M; De Baere T; Hammel P; Sa Cunha A; Lucchese A; Fuks D; Coriat R; Gallois C; Touchefeu Y; Maillet M; Trouilloud I; Rompteaux P; Carbonnel F; Soularue E
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101607. PubMed ID: 33662776
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
    Teodosescu A; Chan I; Elder J; Wu M
    Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
    Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
    Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. pancreatic ductal adenocarcinoma with mismatch repair deficiency resected after long-term observation.
    Ogasawara N; Imamura T; Koyama R; Inoshita N; Nakayama A; Hattori D; Ito Y; Sato Y; Tamura T; Hashimoto M
    Clin J Gastroenterol; 2020 Oct; 13(5):959-968. PubMed ID: 32424776
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
    Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
    Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas.
    Fraune C; Simon R; Hube-Magg C; Makrypidi-Fraune G; Kluth M; Büscheck F; Amin T; Viol F; Fehrle W; Dum D; Höflmayer D; Burandt E; Clauditz TS; Perez D; Izbicki J; Wilczak W; Sauter G; Steurer S; Schrader J
    Endocr Pathol; 2020 Jun; 31(2):182-189. PubMed ID: 32144630
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An Emerging Paradigm for Germline Testing in pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
    Rainone M; Singh I; Salo-Mullen EE; Stadler ZK; O'Reilly EM
    JAMA Oncol; 2020 May; 6(5):764-771. PubMed ID: 32053139
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Endoscopic full thickness resection for early colon cancer in Lynch syndrome.
    Langers AMJ; Boonstra JJ; Hardwick JCH; van der Kraan J; Farina Sarasqueta A; Vasen HFA
    Fam Cancer; 2019 Jul; 18(3):349-352. PubMed ID: 31111311
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Comprehensive cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of pancreatic cancer Patients Receiving Neoadjuvant treatment.
    Yoon KA; Woo SM; Kim YH; Kong SY; Lee MK; Han SS; Kim TH; Lee WJ; Park SJ
    Gut Liver; 2019 Nov; 13(6):683-689. PubMed ID: 30970447
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Germline Variants and Risk for pancreatic cancer: A Systematic Review and Emerging Concepts.
    Zhan W; Shelton CA; Greer PJ; Brand RE; Whitcomb DC
    Pancreas; 2018 Sep; 47(8):924-936. PubMed ID: 30113427
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. cancer risk and survival in
    Møller P; Seppälä TT; Bernstein I; Holinski-Feder E; Sala P; Gareth Evans D; Lindblom A; Macrae F; Blanco I; Sijmons RH; Jeffries J; Vasen HFA; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen JT; Jenkins MA; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Valentin MD; Frayling IM; Plazzer JP; Pylvanainen K; Genuardi M; Mecklin JP; Moeslein G; Sampson JR; Capella G;
    Gut; 2018 Jul; 67(7):1306-1316. PubMed ID: 28754778
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.
    Riazy M; Kalloger SE; Sheffield BS; Peixoto RD; Li-Chang HH; Scudamore CH; Renouf DJ; Schaeffer DF
    Mod Pathol; 2015 Oct; 28(10):1383-9. PubMed ID: 26226846
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.
    Mastoraki A; Chatzimavridou-Grigoriadou V; Chatzipetrou V; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
    J Gastrointest Cancer; 2014 Sep; 45(3):256-61. PubMed ID: 24756831
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Hereditary gastrointestinal neoplasias].
    Fendrich V; Bartsch DK
    Z Gastroenterol; 2005 Feb; 43(2):219-25. PubMed ID: 15700217
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.